Abstract-Endothelial dysfunction contributes to cardiovascular diseases, including hypertension, atherosclerosis, and coronary artery disease, which are also characterized by insulin resistance. Insulin resistance is a hallmark of metabolic disorders, including type 2 diabetes mellitus and obesity, which are also characterized by endothelial dysfunction. Metabolic actions of insulin to promote glucose disposal are augmented by vascular actions of insulin in endothelium to stimulate production of the vasodilator nitric oxide (NO). Indeed, NO-dependent increases in blood flow to skeletal muscle account for 25% to 40% of the increase in glucose uptake in response to insulin stimulation. Phosphatidylinositol 3-kinase-dependent insulin-signaling pathways in endothelium related to production of NO share striking similarities with metabolic pathways in skeletal muscle that promote glucose uptake. Other distinct nonmetabolic branches of insulin-signaling pathways regulate secretion of the vasoconstrictor endothelin-1 in endothelium. Metabolic insulin resistance is characterized by pathway-specific impairment in phosphatidylinositol 3-kinase-dependent signaling, which in endothelium may cause imbalance between production of NO and secretion of endothelin-1, leading to decreased blood flow, which worsens insulin resistance. Therapeutic interventions in animal models and human studies have demonstrated that improving endothelial function ameliorates insulin resistance, whereas improving insulin sensitivity ameliorates endothelial dysfunction. Taken together, cellular, physiological, clinical, and epidemiological studies strongly support a reciprocal relationship between endothelial dysfunction and insulin resistance that helps to link cardiovascular and metabolic diseases. In the present review, we discuss pathophysiological mechanisms, including inflammatory processes, that couple endothelial dysfunction with insulin resistance and emphasize important therapeutic implications. Key Words: diabetes mellitus Ⅲ endothelium Ⅲ hypertension Ⅲ insulin I nsulin resistance is typically defined as decreased sensitivity and/or responsiveness to metabolic actions of insulin that promote glucose disposal. This important feature of diabetes, obesity, glucose intolerance, and dyslipidemia is also a prominent component of cardiovascular disorders, including hypertension, coronary artery disease, and atherosclerosis, which are characterized by endothelial dysfunction. 1 Conversely, endothelial dysfunction is present in diabetes, obesity, and dyslipidemias. 2 Moreover, it is firmly established that these metabolic disorders are major risk factors for cardiovascular diseases. 3 In addition to its essential metabolic actions, insulin has important vascular actions that involve stimulation of the production of nitric oxide (NO) from endothelium, leading to vasodilation, increased blood flow, and augmentation of glucose disposal in skeletal muscle. 4 Elucidation of insulin-signaling pathways regulating endothelial production of NO reveals strik...